Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On? - ARK Genomic Revoluti

On Tuesday, Cathie Wood-led Ark Invest made a significant move by selling over $6.5 million worth of Tesla Inc (NASDAQ:TSLA) shares. This sale comes amid Tesla’s rebound ahead of its Q3 results announcement, marking a continuation of Ark's selling spree of the EV maker's stock.

The Tesla Trade

Through its flagship Ark Innovation ETF (NYSE:ARKK), Ark sold 26,248 shares of the Elon Musk-led automaker. The transaction was valued at $6.7 million, based on Tesla’s closing price of $254.92 on Tuesday.

A day earlier, Ark Invest, through the Innovation ETF sold 7,759 Tesla shares valued at approximately $1.97 million. Investors have been wary due to Tesla's successive price cuts and their potential impact on margins. Ark has been a seller of Tesla since mid-June, even as they remain bullish about its prospects.

Wood has expressed her belief in Tesla, emphasizing its potential upside over the next five years, especially in the expansion of artificial intelligence. She sees more promise in Tesla than in Nvidia, despite the latter's entry into the one-trillion-dollar market capitalization club.

Other Key Trades:

CRISPR Therapeutics AG (NASDAQ:CRSP) – Ark Invest bought 200,999 shares, increasing the ETF's holding by 0.1493 through ARKK and ARK Genomic Revolution ETF (BATS:ARKG).
Nurix Therapeutics Inc (NASDAQ:NRIX) – 78,591 shares were added, marking a 0.031% increase in the ETF's holding through ARKG.
Ionis Pharmaceuticals Inc (NASDAQ:IONS) – Ark sold 48,500 shares, reducing the ETF's stake by 0.1484% through ARKG.

Wood's confidence in Tesla is underscored by her perspective on the company's autonomous and robotaxi potential, anticipating significant revenue and margin expansion ahead for the EV maker.

Photo Courtesy: Shutterstock.com

Engineered by Benzinga Neuro, Edited by Shivdeep Dhaliwal

The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.

ARKGARK Genomic Revolution ETF

$29.57-1.24%

Overview

ARKKARK Innovation ETF

$76.40-1.38%

CRSPCRISPR Therapeutics AG

$55.49-2.24%

IONSIonis Pharmaceuticals Inc

$75.78-1.36%

NRIXNurix Therapeutics Inc

$17.010.24%

TSLATesla Inc

$386.32-1.44%

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.